The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo
- PMID: 15818329
- DOI: 10.1097/01.tp.0000157278.02848.c7
The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo
Abstract
Extracorporeal photopheresis (ECP) may represent an alternative to immunosuppression, as a means of reducing rejection after thoracic organ transplantation. The mechanism by which ECP exerts its protective effects has, until now, remained elusive. We analyzed peripheral blood mononuclear cells of four children with chronic heart and lung transplant rejection, who received ECP in addition to conventional immunosuppressive treatment. The effects of ECP were evaluated at each cycle, comparing blood samples from the same patient collected before and after treatment. In vitro, peripheral blood mononuclear cells treated with ECP undergo apoptosis and are phagocytosed by immature dendritic cells, which, in turn, acquire a tolerogenic phenotype. The frequency of T cells, with a regulatory phenotype and strong suppressive activity, was significantly increased in the blood of ECP-treated patients. The immunomodulatory effects of ECP may be explained by its ability to increase the frequency of regulatory T cells with inhibitory action on transplant immune rejection.
Similar articles
-
[Immunological monitoring of the efficacy of extracorporeal photopheresis for prevention of kidney transplant rejection].Urologiia. 2020 Sep;(4):73-78. Urologiia. 2020. PMID: 32897018 Russian.
-
Indication-specific immunomodulatory effects of extracorporeal photopheresis: A pilot study in heart transplanted patients.J Clin Apher. 2018 Oct;33(5):591-599. doi: 10.1002/jca.21647. Epub 2018 Sep 3. J Clin Apher. 2018. PMID: 30176056
-
Extracorporeal photopheresis: from solid organs to face transplantation.Transpl Immunol. 2009 Jul;21(3):117-28. doi: 10.1016/j.trim.2009.04.005. Epub 2009 May 3. Transpl Immunol. 2009. PMID: 19409991 Review.
-
Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation.Front Immunol. 2021 Aug 10;12:676175. doi: 10.3389/fimmu.2021.676175. eCollection 2021. Front Immunol. 2021. PMID: 34447372 Free PMC article.
-
Extracorporeal photopheresis after heart transplantation.Immunotherapy. 2014;6(8):927-44. doi: 10.2217/imt.14.69. Immunotherapy. 2014. PMID: 25313571 Review.
Cited by
-
Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.J Clin Med. 2024 Oct 8;13(19):5995. doi: 10.3390/jcm13195995. J Clin Med. 2024. PMID: 39408056 Free PMC article.
-
Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis.J Transl Med. 2024 Mar 14;22(1):276. doi: 10.1186/s12967-024-05045-6. J Transl Med. 2024. PMID: 38486224 Free PMC article.
-
The effect of UVA light/8-methoxypsoralen exposure used in Extracorporeal Photopheresis treatment on platelets and extracellular vesicles.PLoS One. 2024 Feb 28;19(2):e0293687. doi: 10.1371/journal.pone.0293687. eCollection 2024. PLoS One. 2024. PMID: 38416722 Free PMC article.
-
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers.Front Immunol. 2023 Feb 17;14:1086006. doi: 10.3389/fimmu.2023.1086006. eCollection 2023. Front Immunol. 2023. PMID: 36875063 Free PMC article. Review.
-
Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD009759. doi: 10.1002/14651858.CD009759.pub4. Cochrane Database Syst Rev. 2022. PMID: 36166494 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources